Use of Nasal Nitric Oxide Testing in Improving Primary Ciliary Dyskinesia Clinical Care

Part of paid clinical trials in Little Rock, Arkansas.

Sponsor
Arkansas Children's Hospital Research Institute
Study ID
NCT05287022
Status
Recruiting
Apply to this trial

Conditions

  • Primary Ciliary Dyskinesia

Eligibility Criteria

Sex
ALL
Age
2 Years - 99 Years
Healthy Volunteers
Not accepted

Study Details

this study is aiming at learning more about primary ciliary dyskinesia (PCD) and tests that are used to diagnose this condition. One purpose of this study is to measure the level of nitric oxide in the nasal passages and examine how often the results correlate with other tests currently done to make the diagnosis.

Key Dates

Start date
Jun 14, 2021
Status verified
Jan 2025
Primary completion
Jun 30, 2030
Completion
Jun 30, 2030

Study Design

Enrollment
150 participants (estimated)

Primary Outcome Measure

Measuring nasal nitric oxide in comparison to ciliary biopsy and genetic testing for the diagnosis of PCD [ Time Frame: throughout the study, an average of 3 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Arkansas Children's HospitalLittle RockArkansas72202
Zena Ghazala

Find similar trials in Little Rock, AR

By research site
Arkansas Children's Hospital· Little Rock, AR

Related Studies